Business Context and Reporting Period
This Form 6-K filing by Lloyds Banking Group plc is a regulatory news service announcement dated 21 January 2010. The document serves as a notification of transactions involving Directors and Persons Discharging Managerial Responsibilities (PDMR) under the Disclosure and Transparency Rules (DTR 3.1.2 R). It details monthly share purchases made under the Lloyds TSB Group Shareplan.
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, or debt metrics. The only financial data provided relates to the specific share transactions:
- Transaction Type: Monthly share purchase under the Lloyds TSB Group Shareplan.
- Share Class: Ordinary shares of 10p each.
- Transaction Price: 57.2 pence per share.
- Transaction Date: 20 January 2010.
- Shares Acquired: Approximately 270 shares per executive (ranging from 270 to 271).
Material Changes
The filing reports incremental increases in the shareholdings of seven executives and PDMRs. The total percentage holding following the notification is described as minimal. No material changes to the company's financial position, operations, or capital structure are disclosed in this document.
Guidance, Outlook, and Risks
This document contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is strictly a compliance filing regarding insider share ownership.
Important Facts for Investors
- Executive Participation: Seven senior executives (J.E. Daniels, A.G. Kane, G.T. Tate, T.J.W. Tookey, H.A. Weir, A.S. Risley, and C.F. Sergeant) participated in the share purchase plan.
- Shareholding Composition: Total holdings for these individuals include direct registered shares, shares held via nominees (Equiniti, LR Nominees, HSDL), and conditional awards under the Lloyds TSB long-term incentive plan.
- Market Price Context: The transaction price of 57.2 pence reflects the market value of the stock on 20 January 2010.
- No Financial Performance Data: Investors should not use this filing to assess the bank's financial health, liquidity, or profitability.